Every year, researchers funded by EP PerMed, the European Union, and our regional / national partner organisations produce a substantial number of research results. For these results to benefit society, they must be made available to the relevant people and used to generate further impact.
Effective communication is vital for projects receiving financial support through EP PerMed to demonstrate the impact of spending, raise public awareness, ensure project transparency and maximise uptake of results by stakeholders, the scientific community and the public. Effective communication increases project visibility, fosters collaboration by building networks, enhances the reputation of participating organisations and ultimately helps ensure that significant investment in research and innovation translates into real-world benefits for society and the economy.
The results of the project can be tangible (e.g. innovative solutions, proof of feasibility, scientific publications, data, engineered results and processes such as software, algorithms, prototypes, protocols and new infrastructures) or intangible (e.g. know-how, policy recommendations, guidelines, trained researchers and networks). These results may or may not be protected, and any rights attached to them, including intellectual property rights, must be considered. Key results are the outputs generated during project implementation. These results can have an impact either during or after funded projects have finished, through the actions of project partners or other stakeholders who access these results and build on them.
Mandatory elements in all communication activities
All communication and dissemination activities related to EP PerMed and its funded projects (e.g. articles, websites, posters, press releases and social media posts) must:
- Acknowledge the funding/support received from EP PerMed and the involved regional and national funding organisations, using the wording specified in the rules of the corresponding funding scheme or call. For example, this could be worded as follows: “This project received funding from [name of funding organisation, or an acknowledgment as requested by your national funding organisation] under the frame of the European Partnership for Personalised Medicine, EP PerMed, (GA N° 101137129 of the EU Horizon Europe Research and Innovation Programme)”
- Show the EP PerMed logo as well as the “co-funded by the European Union” logo as well as the logos of the concerned regional and national funding organisations
- Download the EP PerMed logo pack
- More information on the usage of the “co-funded by the European Union” logo can be found here
- For the use of the logos of regional and national funding organisation, the respective contact points or Joint Call Secretariats should be contacted
- Include a disclaimer, e.g. “The views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Partnership for Personalised Medicine (EP PerMed), national/regional funding organisations, the European Union or the European Commission. Neither of these parties can be held responsible for them.”
Support from EP PerMed
EP PerMed supports the communication and dissemination of your project through a variety of tools, some of which are listed below. Furthermore, EP PerMed will actively raise your profile within European institutions by proposing your project for relevant EU events, reports, articles and briefings.
Project Database
The EP PerMed project database lists transnational research and innovation projects in personalised medicine funded by EP PerMed and the predecessor ERA PerMed. Project data includes runtime, partners, funders, a project description, a list of scientific publications and more. This data was provided directly to EP PerMed or ERA PerMed by the project coordinators. The database also targets funders and research project management agencies, making projects visible to national policymakers and research organisations.
If you would like to request any changes to your project, please contact the relevant call secretariat.
Social Media
EP PerMed currently has a presence on LinkedIn and YouTube. We promote all funded research projects through our channels, particularly on LinkedIn, where we feature individual posts at the beginning of the projects. If you are active on LinkedIn or YouTube, we are also happy to promote your project’s posts and videos. Please tag EP PerMed so that we can share your project progress with our wider audience.
For questions regarding social media, please contact: eppermed@dlr.de
Video Competition
To enhance the visibility and impact of research in personalised medicine, EP PerMed organises a video competition for young researchers involved in projects funded under ERA PerMed or EP PerMed. The EP PerMed Video Competition provides a platform for young researchers involved in ERA PerMed and EP PerMed funded projects to showcase their research work in personalised medicine through short, creative and engaging videos. This initiative aims to enhance the visibility of cutting-edge research, strengthen scientific communication skills, and foster collaboration within the research consortia. By presenting their projects in an accessible format, participants contribute to increasing outreach and awareness of personalised medicine research and its possible impact on healthcare.
For questions regarding the video competition, please contact: EPPerMed@agencerecherche.fr
Success Stories & Best Practice Examples
The EP PerMed success stories highlight the remarkable achievements and outcomes of projects funded under the European Research Area Network, ERA-Net ERA PerMed, and EP PerMed. These stories demonstrate the tangible impact of research in personalised medicine, from groundbreaking scientific discoveries to advancements in clinical practice, innovative methodologies, and collaborations that drive progress in healthcare.
To support personalised medicine implementation, EP PerMed will not only support personalised medicine research, but also continuously map and communicate on progress and achievements within all personalised medicine related areas. These Best Practice Examples include not only innovations and successful implementation in the clinic or even standard care, but can also be supporting (political) frameworks, successful international or interdisciplinary collaboration or citizen engagement or dissemination campaigns.
If you would like to suggest a project to be considered as a best practice example, please complete our form.
Special Newsletter Issues
Special editions of our newsletter (e.g. newsletter on the JTC2024) introduce a wider audience to all the projects that have received funding within a call.
Distinguishing between Communication, Dissemination and Exploitation Activities
In research and innovation projects, communication involves informing and engaging a broad audience about the project’s existence and purpose. Dissemination focuses on sharing project results with specific stakeholders to ensure they reach the people who can make use of them. Exploitation, meanwhile, aims to actively apply and utilise the project’s outcomes in order to create tangible societal, financial or scientific benefits, often in the form of practical applications, products or services. Exploitation strategies often involve partnerships with industry, technology transfer offices and innovation agencies. These strategies may include licensing agreements, spin-offs, start-ups, and collaborations with regulatory bodies and standardisation organisations.
These three activities are complementary and should work together to maximize the project’s impact. Communication builds the foundation by generating interest, dissemination ensures knowledge is shared effectively, and exploitation translates that knowledge into real-world applications and benefits.
Communication
Inform, promote and communicate activities and results
For whom
Citizens, stakeholders and the media
How
✓ Having a well-designed strategy
✓ Conveying clear messages
✓ Using the right channels
When
From the start until the end of the action
Why
✓ Engage with stakeholders
✓ Attract the best experts
✓ Raise awareness of how public money is spent
✓ Show the success of European collaboration
Dissemination
Make knowledge and results
publicly available free-of-charge
For whom
For those who can learn and benefit from the results, such as: scientists, industry, public authorities, policymakers, civil society
How
Publishing results in:
✓ Scientific magazines
✓ Scientific and/or targeted conferences
✓ Databases
When
✓ Anytime, as soon as results become available
✓ Up to four years after the end of the project
Why
✓ Maximise the impact of the action
✓ Allow other researchers to go a step forward
✓ Contribute to the advancement of world class
knowledge
✓ Make scientific results a common good
Exploitation
Make concrete use of results
for commercial, societal and political purposes
For whom
For those who can take the results forward or invest in them, such as: researchers, stakeholders,
industry (also SMEs), public authorities, policymakers, civil society
How
✓ Creating roadmaps, prototypes, software
✓ Sharing knowledge, skills, data
When
✓ Towards the end of the action and beyond,
as soon as exploitable results are available
✓ Up to four years after the end of the project
Why
✓ Lead to new legislation or recommendations
✓ For the benefit of innovation, the economy
and society
✓ Help to tackle a problem and respond to
an existing demand
Further information on this topic is available in the the ‘Disseminating and exploiting results – A starter kit for EU-funded research and innovation projects’ brochure published by the European Research Executive Agency (REA).
European Commission Tools to Support Communication, Dissemination and Exploitation
Horizon Magazine
Communication
The latest news and features about thought-provoking science and innovative research projects funded by the EU.
Horizon Dashboard
Dissemination, Exploitation
An intuitive and interactive knowledge platform where you can extract statistics and data on EU research and innovation programmes – sorted by topics, countries, organisations, sectors, as well as individual projects and beneficiaries.
Horizon Results Platform
Dissemination, Exploitation
A public platform that hosts and promotes research results, thereby widening exploitation opportunities. It helps to bridge the gap between research results and generating value for economy and society. You can create your own page to showcase your results, find collaboration opportunities and get inspired by the results of others.
Horizon Results Booster
Dissemination, Exploitation
A free-of-charge platform to benefit from one of these services:
- Portfolio dissemination & exploitation strategy
- Business plan development
- Go-to-market support.
Innovation Radar
Dissemination, Exploitation
A data-driven method focused on the identification of high-potential innovations and the key innovators behind them in EU-funded research and innovation projects.
Horizon Standardisation Booster
Dissemination, Exploitation
An initiative that supports European research and innovation projects to valorise results through standardisation, supporting them to contribute to the creation of new standards or the revision of existing standards.
CORDIS
Communication, Dissemination, Exploitation
Multilingual articles and publications that highlight research results, based on an open repository of EU project information.
Research and Innovation success stories
Communication, Dissemination, Exploitation
A collection of the most recent success stories from EU-funded research & innovation.
Open Research Europe Platform
Dissemination, Exploitation
A platform that makes it easy for beneficiaries of European research and innovation projects to comply with the open access terms of their funding and offers researchers a publishing venue to share their results and insights rapidly.
Open Science
Depending on the individual call texts, publication of the scientific outcomes of the projects are mandatorily subject to open access and a corresponding budget should be allocated for this in the projects budget plan. Research projects funded through EP PerMed are eligible to publish on Open Research Europe (ORE), an open access publishing platform of the European Commission. Additional information is available in a ‘Guide to Open Science in Horizon Europe‘ by the European Commission and the ICPerMed Guide on Open Access in Personalised Medicine.
Science to Policy
Scientific evidence resulting from research and innovation projects helps to inform policymakers about issues at stake in different policy areas. This evidence can inform legislative initiatives and the design of future research and innovation funding programmes, as well as evaluations and international negotiations. This is what citizens expect. Join us in our efforts to ensure that policymaking is evidence-based, leading to better legislation and policies for society. Further information on this topic is available in the ‘Sharing scientific evidence with policymakers – A starter kit for EU funded research & innovation (R&I) projects’ brochure published by the European Research Executive Agency (REA).
Questions?
If you would like to find out more or require support with your communication and dissemination activities, please contact the EP PerMed communications team at: eppermed@dlr.de